Phil Segrave has produced a DVD video on the WHO flu fraud and other issues.
Included are several documents such as the infamous WHO Checklist for Influenza Pandemic Preparedness Planning 1.5.1 rationale and the US CODE, Title 50, Chapter 32, Section 1520a Restrictions on use of human subjects for testing of chemical or biological agents.
Phil did some investigating and concluded WHO sent the genetic code to Baxter and Novartis AG before shipping the virus samples. The statement by Baxter spokesperson Christopher Bona that WHO had sent the virus to Baxter that Baxter then used to contaminate the 72 kilos of vaccine material may have been just an irrevalent spin for the media.
However, the real questionis whether scientists working in a lab contracted to WHO determined the genetic code, and whether the genetic code was manmade or natural. Phil’s point is, if it is proven by an independent research lab in the future, that the genetic code is manmade, and WHO not only failed to make that fact public, but WHO also knowlingly sent a manmade virus to Baxter and Novartis AG, that is grounds for criminal action too.
His video also has a news article about the CDC experimenting with swine, human and pig viruses to develop a vaccine, according to CDC officials, months before the outbreak. In other words, CDC was creating a mixed genetic code virus intentionally to make a vaccine. Months later, the pandemic level 6 occurred because of a virus similar to the CDC project, if not the same virus.
Baxter files for a WHO flu patent one year before the 2009 pandemic: http://www.globalresearch.ca/index.php?context=va&aid=14430
Baxter Files Swine Flu Vaccine Patent a Year Ahead of Outbreak –US20090060950A1 to Baxter International filed 28th August 2008 By Lara 10 Jul 2009 Baxter Vaccine Patent Application US 2009/0060950 A1 –‘In particular preferred embodiments the composition or vaccine comprises more than one antigen…..such as influenza A and influenza B in particular selected from of one or more of the human H1N1, H2N2, H3N2, H5N1, H7N7, H1N2, H9N2, H7N2, H7N3, H10N7 subtypes, of the pig flu H1N1, H1N2, H3N1 and H3N2 subtypes, of the dog or horse flu H7N7, H3N8 subtypes or of the avian H5N1, H7N2, H1N7, H7N3, H13N6, H5N9, H11N6, H3N8, H9N2, H5N2, H4N8, H10N7, H2N2, H8N4, H14N5, H6N5, H12N5 subtypes.’
This is evidence Baxter had the genetic code and the WHO flu virus prior to the pandemic.
Check out: http://www.prisonplanet.com/baxter-files-swine-flu-vaccine-patent-a-year-ahead-of-outbreak.html
See Baxter Vaccine Patent Application US 2009/0060950 A1
“Suitable adjuvants can be selected from mineral gels,
aluminium hydroxide, surface active substances, lysolecithin,
pluronic polyols, polyanions or oil emulsions such as water in
oil or oil in water, or a combination thereof. Of course the
selection of the adjuvant depends on the intended use.
E.g. toxicity may depend on the destined subject organism
and can vary from no toxicity to high toxicity.”
“Three different influenza strains, two A-strains Hiroshima
(HR, H3N2), a New Calcdonia (NC, H1N1) and a B-strain,
Malaysia (MA), were produced in Vero cell cultures. After
virus propagation the infectious virus harvest is inactivated
prior to purification….”
Other questions: If Baxter was engaged in filing vaccine patents for viruses that were not in existence except in a laboratory, would that not indicate Baxter was in the business of creating manmade weaponized viruses prior to the 2009 WHO pandemic? And why does Baxter need outside labs to send them genetic codes and sample viruses when they have the resources to make that determination?
This is a link to a swine flu vaccine patent filed in 1998: http://www.ars.usda.gov/research/patents/patents.htm?serialnum=09197679
Title: Vaccine Against Swine Influenza Virus
Administrator and Immediate Staffs
See also: US Patent Office Full Record
Patent Number: 6287570
Docket Number: 24098
Serial Number: 9197679
Date Patented: 09/11/2001
Animal and Plant Health Inspection Service
November 23, 1998
This invention provides means for protecting swine against influenza virus by administration of an attenuated recombinant vaccinia virus containing inserts of the hemagglutinin (HA) and nucleoprotein (NP) genes of influenza virus, which express the hemagglutinin and nucleoprotein proteins. The vaccine of the invention provides protection from influenza infection. By protecting pigs from infection, the human population is protected from transfer of infection from swine to the human population.
Patricia L. Foley
USDA, Animal and Plant Health Inspection Service
55789 Oak Boulevard
Huxley, IA 50124
If viruses mutate, why file a patent?
It appears Christopher is base in Sweden:
Christopher Bona, Attorney at Law/ Managing Partner Linköping
Direct phone: +46 13 35 62 07
Mobile phone: +46 709 25 26 27
…”Upon learning about the swine flu outbreak in Mexico, Baxter requested a virus sample from WHO to do laboratory testing for potentially developing an experimental vaccine,” company spokesman Christopher Bona told the Tribune…
The Associated Press
DEERFIELD, Ill. (AP) – Specialty drug maker Baxter International Inc. will work with the World Health Organization to develop a vaccine that could stem an outbreak of a deadly swine flu strain in Mexico.
Baxter spokesman Christopher Bona said Saturday that the Deerfield, Ill.-based company has asked the WHO for a sample of the flu strain.
… Swiss drugmaker Novartis AG said on Tuesday it had received the genetic code of the new flu strain and hoped to receive the actual virus in its laboratories “in the near future.” …
Swine flu is a distant relative of the H1N1 form of the human influenza virus but includes genetic material from pig, human and bird viruses.